Contact
Please use this form to send email to PR contact of this press release:
Amicus Therapeutics Receives Positive CHMP Opinion for Approval of Migalastat in Patients with Fabry Disease in European Union
TO:
Please use this form to send email to PR contact of this press release:
Amicus Therapeutics Receives Positive CHMP Opinion for Approval of Migalastat in Patients with Fabry Disease in European Union
TO: